The effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults
- PMID: 9815216
- DOI: 10.1086/314491
The effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults
Abstract
The effect of acute coinfections on plasma human immunodeficiency virus (HIV) load and immune activation markers was evaluated. Thirty-two HIV-infected persons were prospectively enrolled; 18 had pre-illness, acute, and follow-up specimens. Plasma HIV RNA levels were determined by reverse transcriptase-polymerase chain reaction, and serum levels of activation markers, including tumor necrosis factor (TNF)-alpha, soluble (s) TNF receptors (R)-I and -II, interleukin (IL)-2, IL-6, IL-10, sIL-2R, sCD4, and sCD8, were assessed by commercial ELISAs. Median plasma HIV load increased 7. 8-fold during illness (P=.001) and decreased 1.5-fold (P=.01) during convalescence (median, 15 days). Significant virus load reductions were limited to subjects with clinical recovery. By regression analysis, changes in plasma HIV RNA were significantly associated with changes in sTNFR-I, sTNFR-II, and sIL-2R. Increased HIV replication during acute coinfections is associated with in vivo immune activation, which underscores the need to prevent and promptly treat intercurrent illnesses.
Similar articles
-
Plasma levels of soluble CD30, tumour necrosis factor (TNF)-alpha and TNF receptors during primary HIV-1 infection: correlation with HIV-1 RNA and the clinical outcome.AIDS. 1996 Nov;10(13):F45-50. doi: 10.1097/00002030-199611000-00001. AIDS. 1996. PMID: 8931778
-
Residual viraemia in HIV-1-infected patients with plasma viral load <or=20 copies/ml is associated with increased blood levels of soluble immune activation markers.Scand J Immunol. 2008 Dec;68(6):652-60. doi: 10.1111/j.1365-3083.2008.02184.x. Scand J Immunol. 2008. PMID: 19055701
-
Serum HIV-1 RNA levels compared to soluble markers of immune activation to predict disease progression in HIV-1-infected individuals.Int Arch Allergy Immunol. 1998 Jul;116(3):228-39. doi: 10.1159/000023949. Int Arch Allergy Immunol. 1998. PMID: 9693271
-
The effect of tenidap on cytokines, acute-phase proteins, and virus load in human immunodeficiency virus (HIV)-infected patients: correlation between plasma HIV-1 RNA and proinflammatory cytokine levels.J Infect Dis. 1997 Sep;176(3):807-10. doi: 10.1086/517308. J Infect Dis. 1997. PMID: 9291340 Clinical Trial.
-
Cytokines, plasma immune activation markers, and clinically relevant surrogate markers in human immunodeficiency virus infection.Clin Diagn Lab Immunol. 1998 Sep;5(5):597-603. doi: 10.1128/CDLI.5.5.597-603.1998. Clin Diagn Lab Immunol. 1998. PMID: 9729522 Free PMC article. Review. No abstract available.
Cited by
-
African enigma: key player in human immunodeficiency virus pathogenesis in developing countries?Clin Diagn Lab Immunol. 2001 Sep;8(5):864-6. doi: 10.1128/CDLI.8.5.864-866.2001. Clin Diagn Lab Immunol. 2001. PMID: 11527793 Free PMC article. Review. No abstract available.
-
The effects of early syphilis on CD4 counts and HIV-1 RNA viral loads in blood and semen.Sex Transm Infect. 2005 Oct;81(5):380-5. doi: 10.1136/sti.2004.012914. Sex Transm Infect. 2005. PMID: 16199736 Free PMC article.
-
An atypical pneumonia.Respirol Case Rep. 2019 Feb 5;7(3):e00407. doi: 10.1002/rcr2.407. eCollection 2019 Apr. Respirol Case Rep. 2019. PMID: 30766683 Free PMC article.
-
Persistent replication of human immunodeficiency virus type 1 despite treatment of pulmonary tuberculosis in dually infected subjects.Clin Diagn Lab Immunol. 2005 Nov;12(11):1298-304. doi: 10.1128/CDLI.12.11.1298-1304.2005. Clin Diagn Lab Immunol. 2005. PMID: 16275944 Free PMC article.
-
Tuberculosis (TB) and HIV infection are independently associated with elevated serum concentrations of tumour necrosis factor receptor type 1 and beta2-microglobulin, respectively.Clin Exp Immunol. 2000 Oct;122(1):79-84. doi: 10.1046/j.1365-2249.2000.01341.x. Clin Exp Immunol. 2000. PMID: 11012622 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical